Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB) 2025-05-06 22:12
Ascletis Announces Oral and Poster Presentations on ASC47, an Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate for Obesity at the 32nd European Congress on Obesity 2025-05-06 16:55
Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy 2025-05-06 13:00
INTREPID Alliance Releases New Report Highlighting Urgent Gaps in Antiviral Preparedness 2025-05-06 02:16
Genezen and Optieum Biotechnologies Partner to Support cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma 2025-05-05 21:00
How latest genetic data on fertility may be an indicator of chronic disease onset and longevity 2025-05-02 15:59
HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion 2025-05-02 10:00
A Pivotal Phase II/III Clinical Study of Anti-HER2 Bispecific Antibody KN026 Have Met the Primary Endpoint of PFS at Interim Analysis 2025-05-01 09:49
S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial 2025-05-01 08:00
ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care 2025-04-30 21:00
Alphamab Oncology Presented Preclinical Data on Two Novel Bispecific ADCs at the 2025 AACR Annual Meeting 2025-04-30 10:35
Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies 2025-04-30 08:00
Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong Kong 2025-04-30 07:45
Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar 2025-04-29 23:39
Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar 2025-04-29 23:38
PHASE Scientific Earns Prestigious Recognition at 2025 ASCCP Scientific Meeting for Innovation in Urine-Based HPV Screening 2025-04-29 22:00
Metabolon Launches Microbiome Research Solution Combining New Microbiome Panel, Metagenomics Sequencing, and Multiomics Bioinformatics Tools 2025-04-29 21:00
Amorepacific Research Confirms Potential of Microalgal-Derived PDRNs in Skin Regeneration and Wound Healing 2025-04-29 09:00
AI Evolution and Life Sciences: Embracing New Frontiers at Dalton Venture CEO Summit 2025 2025-04-29 07:00
KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS 2025-04-28 21:16
1 20 21 22 23 24 264